# Succinylation: novel molecular mechanisms and prospects for targeted therapy in liver diseases

**Authors:** Jie Zhou, Xiaoling Tian, Yifang Zhou, Nianhua Tan, Bin Chen

PMC · DOI: 10.3389/fmolb.2026.1768199 · Frontiers in Molecular Biosciences · 2026-02-18

## TL;DR

This paper explores how a new protein modification called succinylation affects liver diseases and offers potential new treatments.

## Contribution

The paper systematically outlines the molecular mechanisms of succinylation and its role in liver diseases, proposing novel therapeutic strategies.

## Key findings

- Succinylation modulates metabolic enzymes and epigenetic status in liver diseases.
- It influences the immune microenvironment and contributes to disease progression.
- Potential therapies include drug repurposing and traditional Chinese medicinal compounds.

## Abstract

Succinylation is a novel post-translational modification involving the attachment of a negatively charged succinyl group to lysine residues, which fundamentally alters the structure and function of substrate proteins. The liver, the metabolic center of the body, is a critical target for succinylation because of its high metabolic activity. Growing evidence suggests that succinylation is a core pathological mechanism that bridges hepatic metabolic dysfunction and disease progression by modulating metabolic enzyme activity, influencing epigenetic status, and remodeling the immune microenvironment. This review aimed to systematically outline the molecular features and regulatory networks of succinylation, dissect its mechanistic roles in major liver diseases, and synthesize current therapeutic strategies, including clinical drug repurposing, small-molecule agents, and traditional Chinese medicinal compounds that target this modification. Collectively, these insights offer a novel theoretical framework and promising therapeutic direction for the management of liver diseases.

Circular infographic diagram illustrating the role of succinylation in liver diseases, featuring pathways such as metabolism, epigenetic regulation, immune microenvironment, hepatitis, NAFLD/MASLD, liver failure, liver fibrosis, and HCC, with labeled molecular structures, pathways, proteins, and traditional medicine graphics surrounding the central term “Succinylation.”

## Linked entities

- **Diseases:** hepatitis (MONDO:0002251), liver failure (MONDO:0100192), HCC (MONDO:0007256)

## Full-text entities

- **Genes:** TRIM63 (tripartite motif containing 63) [NCBI Gene 84676] {aka CMH31, IRF, MURF1, MURF2, RNF28, SMRZ}, PKM (pyruvate kinase M1/2) [NCBI Gene 5315] {aka CTHBP, HEL-S-30, OIP3, PK3, PKM2, TCB}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, DUSP1 (dual specificity phosphatase 1) [NCBI Gene 1843] {aka CL100, HVH1, MKP-1, MKP1, PTPN10}, HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha) [NCBI Gene 3030] {aka ECHA, GBP, LCEH, LCHAD, MLCL AT, MTPA}, Hat1 (histone aminotransferase 1) [NCBI Gene 107435] {aka 2410071B14Rik, Hat-1, KAT1}, RAB18 (RAB18, member RAS oncogene family) [NCBI Gene 22931] {aka RAB18LI1, WARBM3}, HK1 (hexokinase 1) [NCBI Gene 3098] {aka CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD}, CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374] {aka CPT I, CPT1, CPT1-L, CPTI-L, L-CPT1}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, TWSG1 (twisted gastrulation BMP signaling modulator 1) [NCBI Gene 57045] {aka TSG}, LACTB (lactamase beta) [NCBI Gene 114294] {aka G24, MRPL56}, HAT1 (histone acetyltransferase 1) [NCBI Gene 8520] {aka KAT1}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, SRSF2 (serine and arginine rich splicing factor 2) [NCBI Gene 6427] {aka PR264, SC-35, SC35, SFRS2, SFRS2A, SRp30b}, PCK1 (phosphoenolpyruvate carboxykinase 1) [NCBI Gene 5105] {aka PCKDC, PEPCK-C, PEPCK1, PEPCKC}, Pgam1 (phosphoglycerate mutase 1) [NCBI Gene 18648] {aka 2310050F24Rik, Pgam-1}, PGK1 (phosphoglycerate kinase 1) [NCBI Gene 5230] {aka HEL-S-68p, MIG10, PGKA}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, Sirt5 (sirtuin 5) [NCBI Gene 68346] {aka 0610012J09Rik, 1500032M05Rik}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, HDAC1 (histone deacetylase 1) [NCBI Gene 3065] {aka GON-10, HD1, KDAC1, RPD3, RPD3L1}, Kat2a (K(lysine) acetyltransferase 2A) [NCBI Gene 14534] {aka 1110051E14Rik, Gcn5, Gcn5l2, mmGCN5}, ALDOA (aldolase, fructose-bisphosphate A) [NCBI Gene 226] {aka ALDA, GSD12, HEL-S-87p}, PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha) [NCBI Gene 5518] {aka HJS2, MRD36, PP2A-Aalpha, PP2AA, PP2AAALPHA, PR65A}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, LDHB (lactate dehydrogenase B) [NCBI Gene 3945] {aka HEL-S-281, LDH-B, LDH-H, LDHBD, TRG-5}, Sirt7 (sirtuin 7) [NCBI Gene 209011], Mff (mitochondrial fission factor) [NCBI Gene 75734] {aka 5230400G24Rik}, PRMT5 (protein arginine methyltransferase 5) [NCBI Gene 10419] {aka HRMT1L5, HSL7, IBP72, JBP1, SKB1, SKB1Hs}, SREBF1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 6720] {aka HMD, IFAP2, SREBP1, bHLHd1}, ARG1 (arginase 1) [NCBI Gene 383], Ifna (interferon alpha complex region) [NCBI Gene 111654] {aka Ifa, Ifa8}, KAT8 (lysine acetyltransferase 8) [NCBI Gene 84148] {aka LIGOWS, MOF, MYST1, ZC2HC8, hMOF}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, OXCT1 (3-oxoacid CoA-transferase 1) [NCBI Gene 5019] {aka OXCT, SCOT}, ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, SUCLA2 (succinate-CoA ligase ADP-forming subunit beta) [NCBI Gene 8803] {aka A-BETA, A-SCS, LINC00444, MTDPS5, SCS-betaA}, ACOX2 (acyl-CoA oxidase 2) [NCBI Gene 8309] {aka BCOX, BRCACOX, BRCOX, CBAS6, THCCox}, PTPA (protein phosphatase 2 phosphatase activator) [NCBI Gene 5524] {aka PARK25, PP2A, PPP2R4, PR53}, HDAC2 (histone deacetylase 2) [NCBI Gene 3066] {aka HD2, KDAC2, RPD3, YAF1}, KAT2A (lysine acetyltransferase 2A) [NCBI Gene 2648] {aka GCN5, GCN5L2, PCAF-b, hGCN5}, PGAM1 (phosphoglycerate mutase 1) [NCBI Gene 5223] {aka HEL-S-35, PGAM-B, PGAMA}, SIRT5 (sirtuin 5) [NCBI Gene 23408] {aka SIR2L5}, NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971] {aka BAR, FXR, HRR-1, HRR1, PFIC5, RIP14}, WDR77 (WD repeat domain 77) [NCBI Gene 79084] {aka HKMT1069, MEP-50, MEP50, Nbla10071, p44, p44/Mep50}, DLD (dihydrolipoamide dehydrogenase) [NCBI Gene 1738] {aka DLDD, DLDH, E3, GCSL, LAD, OGDC-E3}, PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, Oxct1 (3-oxoacid CoA transferase 1) [NCBI Gene 67041] {aka 2610008O03Rik, Oxct, Oxct2a, SCOT, Scot-s}, IDH2 (isocitrate dehydrogenase (NADP(+)) 2) [NCBI Gene 3418] {aka D2HGA2, ICD-M, IDH, IDH-2, IDHM, IDP}, CPT2 (carnitine palmitoyltransferase 2) [NCBI Gene 1376] {aka CPT1, CPTASE, IIAE4}, ACOX1 (acyl-CoA oxidase 1) [NCBI Gene 51] {aka ACOX, AOX, MITCH, PALMCOX, SCOX}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Cpt1a (carnitine palmitoyltransferase 1a, liver) [NCBI Gene 12894] {aka C730027G07, CPTI, Cpt1}, KMT5A (lysine methyltransferase 5A) [NCBI Gene 387893] {aka PR-Set7, PR/SET07, SET07, SET8, SETD8}
- **Diseases:** Hepatitis B virus (HBV) infection (MESH:D006509), Liver fibrosis (MESH:D008103), cancer (MESH:D009369), NAFLD (MESH:D065626), Mitochondrial dysfunction (MESH:D028361), morphological abnormalities (MESH:D000013), Cirrhosis (MESH:D005355), MASLD (MESH:D008107), inflammation (MESH:D007249), non-small cell lung cancer (MESH:D002289), Metabolic dysfunction (MESH:D008659), multi-organ dysfunction (MESH:D009102), gastric cancer (MESH:D013274), fatty liver disease (MESH:D005234), acute liver failure (MESH:D017114), urinary tract infection (MESH:D014552), infection (MESH:D007239), Viral hepatitis (MESH:D014777), hepatic lipid metabolism disorders (MESH:D052439), metastasis (MESH:D009362), liver tumor (MESH:D008113), tissue injury (MESH:D017695), lipid (MESH:D011017), intestinal injury (MESH:D007410), HCC (MESH:D006528), Liver failure (MESH:D017093), hepatic (MESH:D056486), drug (MESH:D000081015)
- **Chemicals:** DATs (MESH:C042577), TCA (MESH:D014233), cholic acid (MESH:D019826), CAY10683 (MESH:C586127), ketone (MESH:D007659), quercetin (MESH:D011794), acetaminophen (MESH:D000082), phosphate (MESH:D010710), succinate (MESH:D019802), Metal- (MESH:D008670), aldehyde (MESH:D000447), Hydroxytyrosol (MESH:C005975), ketone body (MESH:D007657), copper (MESH:D003300), sorafenib (MESH:D000077157), resveratrol (MESH:D000077185), GABA (MESH:D005680), paeoniflorin (MESH:C015423), Glibenclamide (MESH:D005905), Metformin hydrochloride (MESH:D008687), Aspirin (MESH:D001241), amide (MESH:D000577), SucCoA (MESH:C012046), fatty acid (MESH:D005227), ligustrazine (MESH:C017953), crocin (MESH:C029036), bile acid (MESH:D001647), Curcumin (MESH:D003474), Puerarin (MESH:C033607), Lidocaine (MESH:D008012), 3-sucCA (-), berberine (MESH:D001599), ROS (MESH:D017382), glucose (MESH:D005947), alcohol (MESH:D000438), gemcitabine (MESH:D000093542), lysine (MESH:D008239), Allicin (MESH:C006452), 2,3,5,4'-Tetrahydroxystilbene-2-O-beta-D-glucoside (MESH:C093026), lenvatinib (MESH:C531958), astragaloside IV (MESH:C052064), lipid (MESH:D008055), glutamine (MESH:D005973), lipopeptides (MESH:D055666), glutathione (MESH:D005978)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Dioscorea polystachya (Chinese yam, species) [taxon 55575], Mus musculus (house mouse, species) [taxon 10090], Morinda (genus) [taxon 43521], Vibrio alginolyticus (species) [taxon 663], Homo sapiens (human, species) [taxon 9606], Cynomorium (genus) [taxon 51502], Akkermansia muciniphila (species) [taxon 239935]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956679/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956679/full.md

## References

138 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956679/full.md

---
Source: https://tomesphere.com/paper/PMC12956679